Retatrutide, by Soma Pharmaceuticals , represents a promising breakthrough in weight regulation. This dual-action drug combines GLP-1 receptor function with GIP pathway stimulation , showing substantial results in trial studies for body reduction . Researchers believe Retatrutide may represent a different option for people experiencing weight-relat